Elevance Health, Inc. (ELV) operating KPIs
ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3012% below fair value
$420.07−1.95 (-0.46%)
Close on Oct 30, 2026Market cap $91.10BP/E 18.7Yield –
Elevance Health non-GAAP Adj: Net Losses (Gains) on Financial Instruments (Pre-Tax) ($M)
Quarterly figures from Elevance Health's filings and investor materials
Latest, Q3 2026
48
Period ended Sep 30, 2026
Change on a year earlier
+4,700.0%
1 in Q3 2025
History
19 quarters
Since Q1 2022
Sources
15
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Non-GAAP Adj: Net Losses (Gains) on Financial Instruments (Pre-Tax) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q3 2026 | Sep 30, 2026 | 48 | +4,700.0% | 8-K ER (FY2026Q3, 2026-10-21) ↗ |
| Q2 2026 | Jun 30, 2026 | 56 | -57.3% | 8-K ER (FY2026Q2, 2026-07-15) ↗ |
| Q1 2026 | Mar 31, 2026 | 78 | -83.2% | 8-K ER (FY2026Q1, 2026-04-22) ↗ |
| Q4 2025 | Dec 31, 2025 | 57 | -23.0% | 8-K ER (FY2025Q4, 2026-01-28) ↗ |
| Q3 2025 | Sep 30, 2025 | 1 | -99.2% | 8-K ER (FY2026Q3, 2026-10-21) ↗ |
| Q2 2025 | Jun 30, 2025 | 131 | +54.1% | 8-K ER (FY2026Q2, 2026-07-15) ↗ |
| Q1 2025 | Mar 31, 2025 | 464 | +188.2% | 8-K ER (FY2026Q1, 2026-04-22) ↗ |
| Q4 2024 | Dec 31, 2024 | 74 | -78.0% | 8-K ER (FY2025Q4, 2026-01-28) ↗ |
| Q3 2024 | Sep 30, 2024 | 125 | +0.8% | 8-K ER (FY2025Q3, 2025-10-21) ↗ |
| Q2 2024 | Jun 30, 2024 | 85 | -29.8% | 8-K ER (FY2025Q2, 2025-07-17) ↗ |
| Q1 2024 | Mar 31, 2024 | 161 | +42.5% | 8-K ER (FY2025Q1, 2025-04-22) ↗ |
| Q4 2023 | Dec 31, 2023 | 336 | +202.7% | 8-K ER (FY2024Q4, 2025-01-23) ↗ |
| Q3 2023 | Sep 30, 2023 | 124 | +117.5% | 8-K ER (FY2024Q3, 2024-10-17) ↗ |
| Q2 2023 | Jun 30, 2023 | 121 | -47.6% | 8-K ER (FY2024Q2, 2024-07-17) ↗ |
| Q1 2023 | Mar 31, 2023 | 113 | -25.2% | 8-K ER (FY2024Q1, 2024-04-18) ↗ |
| Q4 2022 | Dec 31, 2022 | 111 | – | 8-K ER (FY2023Q4, 2024-01-24) ↗ |
| Q3 2022 | Sep 30, 2022 | 57 | – | 8-K ER (FY2023Q3, 2023-10-18) ↗ |
| Q2 2022 | Jun 30, 2022 | 231 | – | 8-K ER (FY2023Q2, 2023-07-19) ↗ |
| Q1 2022 | Mar 31, 2022 | 151 | – | 8-K ER (FY2023Q1, 2023-04-19) ↗ |
Cite this data
StockData. (2026). Elevance Health Non-GAAP Adj: Net Losses (Gains) on Financial Instruments (Pre-Tax) ($M), quarterly Q1 2022–Q3 2026 [Data set]. Compiled from Elevance Health SEC filings and investor materials. https://stockdatahq.com/stocks/elv/kpis/nongaap_adj_fin_instruments
See every metric in the Elevance Health KPI table. Data updated Oct 28, 2026.